CI-950

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCI-950
Drug Alias NamePD-119229PD-119229CI-950
ClassificationSmall molecules
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParke-Davis Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke-Davis Corp
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A